Parveen Shaheena, Shah Altaf H, Zargar Showkat A, Gulzar G M, Sodhi Jaswinder S, Khan Mushtaq A, Syed Nisar Ahmad, Dar Nazir A
Department of Gastroenterology, Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar, IND.
Department of Medical Oncology, Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar, IND.
Cureus. 2023 Jan 19;15(1):e33953. doi: 10.7759/cureus.33953. eCollection 2023 Jan.
Background Upper gastrointestinal bleeding (UGIB) represents a substantial clinical and economic burden and rebleeding is one of the most important predictors of morbidity and mortality. Identifying patients who are likely to rebleed is a critical component of effectively managing patients with bleeding peptic ulcers. So, the study was undertaken to look for predictors of rebleeding in patients with bleeding peptic ulcers and try to find out the new scoring system to predict rebleeding in our population. Material and methods A retrospective analysis of prospectively maintained hospital data of UGIB patients was done and 480 patients of endoscopically documented peptic ulcers whose complete data was available were taken for study. Results Among the studied patients, men constituted 84.6%, and most of the patients were in the third to sixth decade of life with a mean age of 40.9±15.9 years, 76% were from rural areas. Only males with a mean age of 38.4±19.8 rebled with a rebleeding rate of 2.9% only. Half of the patients who rebled were in shock at the time of presentation. Those who rebled received more units of blood transfusion (mean 3±1.8), had a large mean ulcer size of Forest class IIa and IIb and epinephrine injection monotherapy group with varied statistical significance. Among rebleeders (n=14), eight patients were managed by a second endoscopic therapy, and six (42.8%) rebleeders and 1.25% of patients in total needed surgery. Two patients ultimately died giving overall mortality of 0.4% and mortality of 14.3% among rebleeders. Conclusion Our study found a very low rebleeding rate and mortality which could be explained by a young population with fewer co-morbidities and better response to proton pump inhibitor therapy. The significant parameters related to rebleeding were shock at presentation, degree of smoking, units of blood transfused, ulcer size, and high-risk endoscopic stigmata.
背景 上消化道出血(UGIB)带来了巨大的临床和经济负担,而再出血是发病率和死亡率的最重要预测因素之一。识别可能再出血的患者是有效管理消化性溃疡出血患者的关键组成部分。因此,开展本研究以寻找消化性溃疡出血患者再出血的预测因素,并试图找出适合我国人群的预测再出血的新评分系统。
材料与方法 对前瞻性收集的UGIB患者的医院数据进行回顾性分析,选取480例有内镜记录且资料完整的消化性溃疡患者进行研究。
结果 在研究患者中,男性占84.6%,大多数患者年龄在30至60岁之间,平均年龄为40.9±15.9岁,76%来自农村地区。仅平均年龄为38.4±19.8岁的男性出现再出血,再出血率仅为2.9%。一半的再出血患者在就诊时处于休克状态。再出血患者接受了更多单位的输血(平均3±1.8),平均溃疡面积较大,属于 Forrest 分级 IIa 和 IIb 级,以及肾上腺素注射单一疗法组,具有不同的统计学意义。在再出血患者(n = 14)中,8例患者接受了第二次内镜治疗,6例(42.8%)再出血患者和1.25%的患者总共需要手术治疗。2例患者最终死亡,总体死亡率为0.4%,再出血患者的死亡率为14.3%。
结论 我们的研究发现再出血率和死亡率非常低,这可能是由于研究人群年轻、合并症较少以及对质子泵抑制剂治疗反应较好所致。与再出血相关的显著参数包括就诊时休克、吸烟程度、输血量、溃疡大小和高危内镜下表现。